UNI-EN 112:Current report 112 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 112 | / | 2013 | | ||||||
| Date of issue: | 2013-08-19 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 112 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares of the Company: Date and time of Operation Number Unit price settlement of shares (BGN) 14.8.2013 Sale 1 000 3.2900 14.8.2013 Sale 6 000 3.2900 16.8.2013 Sale 4 400 3.2900 16.8.2013 Sale 600 3.2900 16.8.2013 Sale 5 700 3.2900 19.8.2013 Sale 600 3.2900 19.8.2013 Sale 5 700 3.2900 19.8.2013 Sale 600 3.2900 19.8.2013 Sale 5 700 3.2900 19.8.2013 Sale 600 3.2900 19.8.2013 Sale 5 700 3.2900 19.8.2013 Sale 300 3.2950 19.8.2013 Sale 200 3.2950 19.8.2013 Sale 6 000 3.2950 19.8.2013 Sale 3 800 3.2950 19.8.2013 Sale 6 000 3.2950 19.8.2013 Sale 6 000 3.2950 19.8.2013 Sale 3 235 3.2950 19.8.2013 Sale 5 500 3.2950 19.8.2013 Sale 6 000 3.2950 19.8.2013 Sale 5 995 3.2950 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. Legal grounds: Art.160.4 of the Act on Trading in Financial Instruments of 29 July 2005. Signatures of individuals authorized to represent the Company: Ognian Donev | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 112 re insiders transactions.doc Current report 112 re insiders transactions.doc | Current report 112 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-08-19 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
